Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma, Follicular 67Lymphoma, Large B-Cell, Diffuse 66Lymphoma, Non-Hodgkin 59Leukemia, Lymphocytic, Chronic, B-Cell 49Lymphoma 48Lymphoma, Mantle-Cell 28Lymphoma, B-Cell, Marginal Zone 23Recurrence 16Lymphoma, B-Cell 14Burkitt Lymphoma 11Neoplasms 7Leukemia 6Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large-Cell, Anaplastic 5Waldenstrom Macroglobulinemia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myasthenia Gravis 3Hematologic Diseases 3Lymphoproliferative Disorders 2Lymphatic Diseases 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Arthritis, Rheumatoid 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Opsoclonus-Myoclonus Syndrome 1Neuroblastoma 1Neoplasms by Histologic Type 1Myelodysplastic Syndromes 1Limb-girdle muscular dystrophy, type 2C 1Leukemia, Myeloid, Acute 1

Interventions

Doxorubicin 6Dexrazoxane 6Razoxane 5Vincristine 4Cyclophosphamide 4Radiotherapy 3Etoposide 3Prednisone 2Methotrexate 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Carvedilol 2Bleomycin 2schizandrin 1pegfilgrastim 1hydrocortisone hemisuccinate 1fructus schizandrae, radix ginseng, radix ophiopogonis drug combination 1empagliflozin 1Watchful Waiting 1VAP-cyclo protocol 1Trastuzumab 1Taxes 1Tamoxifen 1Rituximab 1Ramipril 1Radiation 1Prednisolone 1Paclitaxel 1Observation 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Cardiotoxicity × Rituximab × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡